Key facts
- This page summarizes Daniel R. Omstead's Form 4 filing for TEKLA HEALTHCARE INVESTORS (HQH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Sep 2023, 17:34.
Daniel R. Omstead - 25 Sep 2023 Form 4 Insider Report for TEKLA HEALTHCARE INVESTORS (HQH)
- Reporting relationship
- President, Director
- Issuer ticker
- HQH
- Reported as of
- 25 Sep 2023
- Net transaction value
- +$148,515
- SEC form
- 4
- Accepted by SEC
- 25 Sep 2023, 17:34:14 UTC
- Prior SEC filing
- 20 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel R. Omstead
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel R. Omstead filed Form 4 for TEKLA HEALTHCARE INVESTORS (HQH) on 25 Sep 2023.
Change
- Previous filing in this sequence was filed on 20 Sep 2023.
- Current net transaction value: +$148,515.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HQH
transaction
Shares of Beneficial Interest
Purchase
- Transaction value
- $148,515
- Shares
- +9,500
- Change %
- +5.6%
- Price
- $15.63
- Shares after
- 178,269
- Date
- 25 Sep 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.